Results 21 to 30 of about 7,152 (164)
Angiogenic activity in the sera of patients with post-kidney transplant erythrocytosis
Post-kidney transplant erythrocytosis (PTE) is one of the hematological complications in the renal transplant patients. While its pathogenesis still remains to be elucidated completely, a number of therapies are available for the management of PTE.
Chokri Maktouf +6 more
doaj +1 more source
Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis
Here we critically evaluate the role of elevated hematocrit as the principal determinant of thrombotic risk in polycythemia and erythrocytosis, defined by an expansion of red cell mass.
Victor R. Gordeuk +2 more
doaj +1 more source
The diagnosis and management of erythrocytosis [PDF]
Erythrocytosis is an increase in the number of red blood cells. In a recent study from the United States, the prevalence of primary erythrocytosis (known as polycythaemia vera) was 44-57 per 100 000.1 The prevalence of secondary erythrocytosis is ...
C. Keohane +5 more
core +1 more source
Evidence on the effect of long-term exposure to fine particulate matter (PM2.5) on erythrocytosis and thrombocytosis prevalence was limited. We aimed to investigate the association of PM2.5 and its constituents with the risks of erythrocytosis and ...
Yiquan Zheng +13 more
doaj +1 more source
Erythrocytosis is associated with intradialytic hypotension: a case series
Background For patients with end stage renal disease undergoing hemodialysis, erythrocytosis occurs rarely. Erythrocytosis increases the risk of thrombosis, which is a common complication in hemodialysis patients.
Shree Agrawal +7 more
doaj +1 more source
Familial erythrocytosis 2 and von Hippel-Lindau disease in the same pediatric patient
Background: Patients with familial erythrocytosis type 2 have no increased risk of von Hippel-Lindau-associated tumors, although mutations in the VHL gene cause both pathologies.
Paulina M. Núñez-Martínez +6 more
doaj +1 more source
Background Erythrocytosis, a rare paraneoplastic syndrome, generally occurs in patients with clear cell renal cell carcinoma and has never been reported in patients with chromophobe renal cell carcinoma.
Renbo Guo +4 more
doaj +1 more source
Background: Anemia is common in patients with nephrotic syndrome (NS) for various reasons. Furthermore, anemia can occur in patients with chronic kidney disease (CKD) predominantly owing to inappropriately low erythropoietin (EPO) production relative to ...
Ratna Acharya, Kiran Upadhyay
doaj +1 more source
RECENT INSIGHTS INTO SECONDARY ERYTHROCYTOSIS: PART I. ETIOLOGY
Introduction. The development of secondary erythrocytosis is associated with a wide range of both hereditary and acquired pathological conditions. Modern advances in medicine have deepened the understanding of the etiology and pathogenesis of secondary ...
Mariia A. Trypilka +2 more
doaj +1 more source
Gain-of-function mutations in the EPAS1/HIF2A gene have been identified in patients with hereditary erythrocytosis that can be associated with the development of paraganglioma, pheochromocytoma and somatostatinoma.
Valéna Karaghiannis +27 more
doaj +1 more source

